Bio Protocol vs Raydium — how do they compare? Bio Protocol trades at Rp513.9 (market cap Rp1,15T, Rp256,3M 24h volume), while Raydium trades at Rp12,227 (market cap Rp3,26T, Rp160,14M 24h volume). The key difference: Raydium is far larger — about 2.8× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 269,3M / 555M RAY (49%) for Raydium. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Raydium for 24 Days on average.
| BIO | RAY | |
|---|---|---|
Market Cap | Rp1,15T | Rp3,26T |
Volume (24h) | Rp256,3M | Rp160,14M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 269,3M / 555M RAY (49%) |
Typical Hold Time | 16 Days | 24 Days |
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Raydium (RAY) is an automated market maker (AMM) and liquidity provider built on the Solana blockchain for the Serum decentralized exchange (DEX). Unlike any other AMMs, Raydium provides on-chain liquidity to a central limit orderbook meaning that funds deposited into Raydium are converted into limit orders which sit on Serum’s orderbooks.
Read more on RAY →